Back to top
more

DaVita (DVA)

(Delayed Data from NYSE)

$161.97 USD

161.97
575,208

+1.87 (1.17%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $161.95 -0.02 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 6% (15 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Top Ranked Growth Stocks to Buy for December 17th

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 17th

Is DaVita HealthCare (DVA) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

DVA vs. CHE: Which Stock Should Value Investors Buy Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

Why Is DaVita HealthCare (DVA) Up 2.9% Since Last Earnings Report?

DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Option Care Health (BIOS) Surges: Stock Moves 7.3% Higher

Option Care Health (BIOS) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

Top Ranked Growth Stocks to Buy for December 5th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 5th:

DVA or CHE: Which Is the Better Value Stock Right Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

Is DaVita HealthCare (DVA) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

The Zacks Analyst Blog Highlights: Samsung, Target and Davita

The Zacks Analyst Blog Highlights: Samsung, Target and Davita

John Blank headshot

A Holiday-Shortened Global Week Ahead

This is going to be a short trading week in the USA. Chief Strategist John Blank doesn't see much in the way of market moving events. Here are Reuters' latest five world market themes, reordered into relative importance for equity traders.

The Zacks Analyst Blog Highlights: Amedisys, DaVita, Tenet and Hanger

The Zacks Analyst Blog Highlights: Amedisys, DaVita, Tenet and Hanger

The Zacks Analyst Blog Highlights: DaVita, Quanta Services, CRA International, NRG Energy and First American Financial

The Zacks Analyst Blog Highlights: DaVita, Quanta Services, CRA International, NRG Energy and First American Financial

Manaswita Ghosh Dutta headshot

4 Healthcare Stocks to Gain From Stellar Q3 Earnings

Prominent activities in the healthcare sector are pushing the sector ahead this quarter.

Top Ranked Momentum Stocks to Buy for November 22nd

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 22nd

Nalak Das headshot

Shrug Off Market Gyrations With These Top 5 Value Picks

A strong rally is unlikely for as long as this trade conflict continues. However, the downside potential will be limited owing to U.S. economic strength.

Why DaVita HealthCare (DVA) Might be Well Poised for a Surge

DaVita HealthCare (DVA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

DVA or CHE: Which Is the Better Value Stock Right Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?

Is (DVA) Outperforming Other Medical Stocks This Year?

Are Investors Undervaluing DaVita HealthCare (DVA) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Nitish Marwah headshot

New Strong Buy Stocks for November 12th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.

DaVita (DVA) Earnings and Revenues Beat Estimates in Q3

DaVita (DVA) raises guidance for 2019 following impressive Q3 results.

DaVita HealthCare (DVA) Surpasses Q3 Earnings and Revenue Estimates

DaVita HealthCare (DVA) delivered earnings and revenue surprises of 24.39% and 1.81%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

What's in the Cards for DaVita (DVA) This Earnings Season?

DaVita (DVA) expects to have gained from calcimimetics in the third quarter.

DaVita HealthCare (DVA) Earnings Expected to Grow: Should You Buy?

DaVita HealthCare (DVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Retain DaVita (DVA) Stock for Now

DaVita (DVA) is gaining steadily from expansion in international markets, strong demand in dialysis services and prudent acquisitions. However, integration risks remain a concern.